D K Subbakrishna
Overview
Explore the profile of D K Subbakrishna including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
130
Citations
1448
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gururaj G, Satishchandra P, Subbakrishna D
Neurol India
. 2018 Mar;
43(1):29-34.
PMID: 29542471
Factors associated with stroke were studied by combination of morbidity and mortality analysis for the period 1986 to 1990. Strokes constituted 6.5-7.8 percent of total neurological registration over a five...
2.
Varghese C, Kaur J, Desai N, Murthy P, Malhotra S, Subbakrishna D, et al.
WHO South East Asia J Public Health
. 2017 Jun;
1(2):159-168.
PMID: 28612792
Background: Tobacco use contributes significantly to the diseases burden in India. Very few tobacco users spontaneously quit. Therefore, beginning 2002, a network of 19 tobacco cessation clinics (TCCs) was set...
3.
Solanki C, Sadana D, Arimappamagan A, Rao K, Rajeswaran J, Subbakrishna D, et al.
J Neurosci Rural Pract
. 2017 May;
8(2):228-235.
PMID: 28479798
Background: The incidence of long-term survival in glioblastoma (GBM), i.e., >3 years, ranges from 3% to 5%. Although extensive research is performed in novel therapies for prolonging survival, there is...
4.
Bhagyavathi H, Mehta U, Thirthalli J, Kumar C, Kumar J, Subbakrishna D, et al.
Psychiatry Res
. 2015 Jul;
229(1-2):264-71.
PMID: 26208988
Understanding the complex relationship among determinants of real-world functioning in schizophrenia patients in remission is important in planning recovery-oriented interventions. We explored two path-analytical models of functioning in schizophrenia. 170...
5.
Babu K, Bhat S, Philips M, Subbakrishna D
Ocul Immunol Inflamm
. 2015 Jul;
24(5):498-502.
PMID: 26173028
Aim: To review the results of QuantiFERON TB gold (QFT-G) in our patient population of presumed ocular tuberculosis and the effect of antitubercular therapy (ATT) on the QFT-G result. Materials...
6.
Mundlamuri R, Sinha S, Subbakrishna D, Prathyusha P, Nagappa M, Bindu P, et al.
Epilepsy Res
. 2015 Jun;
114:52-8.
PMID: 26088885
Objective: This study was conducted to compare the efficacy of phenytoin, valproate and levetiracetam in patients with GCSE. Methods: This randomised controlled prospective study was conducted on 150 patients to...
7.
Gururaj G, Kulkarni G, Rao G, Subbakrishna D, Stovner L, Steiner T
Indian J Public Health
. 2014 Dec;
58(4):241-8.
PMID: 25491515
Background: Headache disorders are common and burdensome throughout the world, placing high demand on health care services. Good information on their prevalence and distribution through sectors of the population are...
8.
Shubrata K, Sinha S, Seshadri S, Girimaji S, Subbakrishna D, Srinath S
J Child Neurol
. 2014 Jul;
30(4):476-82.
PMID: 25038126
This prospective cross-sectional study compared 25 children with pervasive developmental disorder and epilepsy and 25 children having pervasive developmental disorder without epilepsy on pervasive developmental disorder scores, Childhood Autism Rating...
9.
Satishchandra P, Dilipkumar S, Subbakrishna D, Sinha S
Epilepsy Res
. 2014 Jun;
108(7):1238-42.
PMID: 24929679
Purpose: To evaluate the role of intermittent prophylaxis with clobazam in the management of HWE in a long-term prospective study. Material And Methods: Two hundred and sixty patients [M:F -...
10.
Mehta U, Thirthalli J, Bhagyavathi H, Kumar J, Subbakrishna D, Gangadhar B, et al.
Schizophr Res
. 2014 Jun;
157(1-3):70-7.
PMID: 24910445
Schizophrenia patients experience substantial impairments in social cognition (SC) and these deficits are associated with their poor functional outcome. Though SC is consistently shown to emerge as a cognitive dimension...